LPL Financial Welcomes Cornerstone Financial Advisers
SAN DIEGO, May 20, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisors Lance Dumas, AIF®, ChFC®, […]
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the […]
Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
PALO ALTO, Calif., May 20, 2024 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO) today announced its latest portfolio of highly-scalable, high-performing, […]
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for April 2024
Total Overall Revenue up 65% Y/Y from April last year Self-Mining Business Revenue up 73% Y/Y from April last year […]
Shimmick Takes Pivotal Steps to Further Advance Evolution as Leader in Water Infrastructure
Strengthens financial position, setting up the Company for future growth and success Board expands to include new Independent Director and […]
Star Equity Holdings, Inc. Announces 2024 First Quarter Financial Results
Ended the first quarter with cash and cash equivalents of $14.7 million Well positioned to expand existing businesses organically and through […]
Star Equity Holdings Announces Acquisition of Timber Technologies
Enters Engineered Wood Products Market Substantially Improves Cash Flow OLD GREENWICH, Conn., May 20, 2024 (GLOBE NEWSWIRE) — Star Equity […]
iPower’s SuperSuite Supply Chain Business Celebrates a Year of Transformative Growth
RANCHO CUCAMONGA, Calif., May 20, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
Lead Real Estate Co., Ltd. to Participate in Nasdaq Japan IR Event on June 20, 2024
TOKYO, May 20, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd. (Nasdaq: LRE), a Japanese real estate developer of luxury residential […]
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader […]
